Lymphohaematopoietic Growth Factors in Cancer Therapy II

Herausgegeben:Mertelsmann, Roland

• Broschiertes Buch

Produktbeschreibung

Contents: Introduction and Overview
Lymphopoietic Growth Factors: Pathophysiology of T-Cell
Mediated Shock Induced by Bacterial Superantigens - Natural
Killer Cells and Interleukin-2-Activated Killer Cells -
TumourImmunogenicity Induced by Exogenous Interleukins -
Cytokine Gene Therapy of Cancer - Analysis of T-Cell
Receptor Variability in Tumour Infiltrating Lymphocytes -
Clinical Studies with Interleukin-2: An Overview - Clinical
Trials with Local Administration of Lymphopoietic Growth
Factors - Clinical Trials with Interlaukin-2. The Rome
Experience.
Haematopoietic Growth Factors: Lymphohaematopoietic Growth
Factor Use in Lung Cancer Patients - Clinical Trials with
Haematopoietic Growth Factors and Peripheral Blood Stem
Cells

Produktdetails

• ESO Monographs
• Verlag: Springer / Springer Berlin Heidelberg / Springer, Berlin
• Artikelnr. des Verlages: 978-3-642-77803-2
• Softcover reprint of the original 1st ed. 1992
• Seitenzahl: 136
• Erscheinungstermin: 16. Dezember 2011
• Englisch
• Abmessung: 277mm x 210mm x 8mm
• Gewicht: 350g
• ISBN-13: 9783642778032
• ISBN-10: 3642778038
• Artikelnr.: 36118723

Autorenporträt

Prof. Dr. med. Roland Mertelsmann leitet als Ärztlicher Direktor die Abteilung Innere Medizin I, Hämatologie/Onkologie der Medizinischen Universitätsklinik und Poliklinik des Universitätsklinikums Freiburg.

Inhaltsangabe

and Overview.- Lymphopoietic Growth Factors.- Pathophysiology of T-Cell Mediated Shock Induced by Bacterial Superantigens.- Natural Killer Cells and Interleukin-2-Activated Killer Cells.- Tumour Immunogenicity Induced by Exogenous Interleukins.- Cytokine Gene Therapy of Cancer.- Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytes.- Clinical Studies with Interleukin-2: An Overview.- Clinical Trials with Local Administration of Lymphopoietic Growth Factors.- Clinical Trials with Interleukin-2. The Rome Experience.- Haematopoietic Growth Factors.- Lymphohaematopoietic Growth Factor Use in Lung Cancer Patients.- Clinical Trials with Haematopoietic Growth Factors and Peripheral Blood Stem Cells.